Edit |   |
Antigenic Specificity | JNK1+2+3 (THR183+TYR185) |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human, mouse, rat, bovine, dog |
Isotype | n/a |
Format | fluorescein (FITC) conjugate |
Size | 100ul |
Concentration | 1ug/ul |
Applications | IF(IHC-P) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | JNK1+2+3 (T183+Y185) Polyclonal Antibody, FITC Conjugated. • Target Background: JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. |
Immunogen | KLH conjugated synthetic phosphopeptide derived from human JNK1 around the phosphorylation site of Thr183/Tyr185. Immunogen Range: 170-210/427 |
Other Names | Phosphorylated, phospho-JNK; JNK1; PRKM8; SAPK1; JNK-46; JNK1A2; SAPK1c; JNK21B1/2; Mitogen-activated protein kinase 8; MAP kinase 8; MAPK 8; Stress-activated protein kinase 1c; Stress-activated protein kinase JNK1; c-Jun N-terminal kinase 1; MAPK8 |
Gene, Accession # | Gene ID: 5599, SwissProt: P45983 |
Catalog # | bs-1640R-FITC |
Price | |
Order / More Info | JNK1+2+3 (THR183+TYR185) Antibody from BIOSS ANTIBODIES |
Product Specific References | Iriyama, Noriyoshi, et al. (2016) Cancer Med. PubMed: 27726309 |